Acorda Therapeutics Return on Investment 2006-2020 | ACOR

Current and historical return on investment (ROI) values for Acorda Therapeutics (ACOR) over the last 10 years.
Acorda Therapeutics ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2020-06-30 $-0.26B $0.47B -46.92%
2020-03-31 $-0.27B $0.55B -40.94%
2019-12-31 $-0.31B $0.55B -40.55%
2019-09-30 $-0.37B $0.66B -43.10%
2019-06-30 $-0.09B $0.92B -9.27%
2019-03-31 $-0.01B $0.94B -0.53%
2018-12-31 $0.04B $0.96B 4.08%
2018-09-30 $-0.13B $0.94B -14.46%
2018-06-30 $-0.16B $0.95B -17.41%
2018-03-31 $-0.22B $0.89B -23.02%
2017-12-31 $-0.23B $0.85B -23.88%
2017-09-30 $-0.01B $1.01B -1.29%
2017-06-30 $-0.02B $1.02B -1.61%
2017-03-31 $-0.03B $1.00B -3.36%
2016-12-31 $-0.04B $0.99B -3.59%
2016-09-30 $-0.03B $0.96B -3.36%
2016-06-30 $-0.00B $0.98B -0.11%
2016-03-31 $0.02B $0.98B 2.11%
2015-12-31 $0.04B $0.90B 4.05%
2015-09-30 $0.03B $0.87B 3.77%
2015-06-30 $0.03B $0.85B 3.24%
2015-03-31 $0.03B $0.84B 3.92%
2014-12-31 $0.04B $0.83B 5.00%
2014-09-30 $0.05B $0.81B 7.70%
2014-06-30 $0.04B $0.79B 7.19%
2014-03-31 $0.04B $0.45B 8.30%
2013-12-31 $0.03B $0.44B 7.39%
2013-09-30 $0.02B $0.43B 4.68%
2013-06-30 $0.02B $0.41B 4.99%
2013-03-31 $0.01B $0.40B 4.41%
2012-12-31 $0.03B $0.39B 9.12%
2012-09-30 $0.04B $0.25B 16.14%
2012-06-30 $0.05B $0.23B 22.35%
2012-03-31 $0.04B $0.22B 22.19%
2011-12-31 $0.04B $0.21B 19.18%
2011-09-30 $0.03B $0.19B 15.36%
2011-06-30 $0.02B $0.17B 11.37%
2011-03-31 $0.01B $0.16B 7.41%
2010-12-31 $-0.01B $0.16B -6.39%
2010-09-30 $-0.04B $0.15B -25.45%
2010-06-30 $-0.07B $0.13B -47.43%
2010-03-31 $-0.08B $0.13B -53.98%
2009-12-31 $-0.08B $0.14B -47.37%
2009-09-30 $-0.08B $0.16B -42.44%
2009-06-30 $-0.08B $0.18B -38.93%
2009-03-31 $-0.08B $0.20B -39.37%
2008-12-31 $-0.07B $0.21B -41.89%
2008-09-30 $-0.07B $0.23B -48.46%
2008-06-30 $-0.06B $0.12B -56.44%
2008-03-31 $-0.05B $0.13B -53.04%
2007-12-31 $-0.04B $0.07B -64.26%
2007-09-30 $-0.03B $0.08B -62.75%
2007-06-30 $-0.03B $0.08B -97.56%
2007-03-31 $-0.03B $0.02B -188.68%
2006-12-31 $-0.02B $0.03B -223.26%
2006-09-30 $-0.01B $0.00B 62.92%
2006-06-30 $-0.01B $0.01B 62.22%
2006-03-31 $-0.02B $0.01B 90.72%
2005-12-31 $-0.02B $-0.11B 82.24%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.034B $0.192B
Acorda Therapeutics, Inc. is a biotechnology company developing and commercializing neurology therapies for Parkinson's disease, migraine and multiple sclerosis. Acorda has a pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease and multiple sclerosis. Acorda markets three FDA-approved therapies, including AMPYRA? (dalfampridine) Extended Release Tablets, 10 mg.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $142.844B 11.00
Amgen (AMGN) United States $137.433B 14.93
CSL (CSLLY) Australia $91.237B 0.00
Gilead Sciences (GILD) United States $85.379B 12.29
Vertex Pharmaceuticals (VRTX) United States $68.206B 38.06
Regeneron Pharmaceuticals (REGN) United States $65.885B 24.36
Illumina (ILMN) United States $50.158B 57.93
Biogen (BIIB) United States $45.901B 7.86
Moderna (MRNA) United States $27.215B 0.00
Seattle Genetics (SGEN) United States $26.705B 0.00
Genmab (GMAB) Denmark $23.440B 19.28
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $22.942B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.189B 9.25
BioMarin Pharmaceutical (BMRN) United States $21.187B 153.72
Incyte (INCY) United States $20.335B 0.00
Genmab (GNMSF) Denmark $20.293B 60.25
BeiGene (BGNE) Cayman Islands $18.716B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.843B 0.00
BioNTech SE (BNTX) Germany $15.488B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.061B 68.12
Horizon Therapeutics Public (HZNP) Ireland $14.797B 34.62
Exact Sciences (EXAS) United States $12.566B 0.00
Sarepta Therapeutics (SRPT) United States $12.406B 0.00
Galapagos (GLPG) Belgium $12.108B 43.87
QIAGEN (QGEN) Netherlands $11.092B 28.15
ARGENX SE-ADR (ARGX) Netherlands $10.757B 0.00
Bio-Techne Corp (TECH) United States $10.008B 69.26
Immunomedics (IMMU) United States $9.246B 0.00
Novavax (NVAX) United States $9.160B 0.00
Guardant Health (GH) United States $8.115B 0.00
Repligen (RGEN) United States $7.455B 118.33
Ascendis Pharma (ASND) Denmark $7.424B 0.00
Exelixis (EXEL) United States $6.696B 24.35
Emergent Biosolutions (EBS) United States $6.474B 25.65
ACADIA Pharmaceuticals (ACAD) United States $6.344B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.277B 194.46
Vir Biotechnology (VIR) United States $6.209B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.177B 15.37
Mirati Therapeutics (MRTX) United States $5.604B 0.00
Acceleron Pharma (XLRN) United States $5.563B 0.00
MyoKardia (MYOK) United States $5.354B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.020B 0.00
Adaptive Biotechnologies (ADPT) United States $4.994B 0.00
Zai Lab (ZLAB) China $4.548B 0.00
NeoGenomics (NEO) United States $4.332B 1307.67
MorphoSys AG (MOR) Germany $4.218B 55.28
China Biologic Products (CBPO) China $4.177B 23.22
Bluebird Bio (BLUE) United States $4.138B 0.00
Blueprint Medicines (BPMC) United States $4.092B 0.00
Halozyme Therapeutics (HALO) United States $3.864B 0.00
Amicus Therapeutics (FOLD) United States $3.776B 0.00
Global Blood Therapeutics (GBT) United States $3.713B 0.00
Arena Pharmaceuticals (ARNA) United States $3.621B 0.00
Denali Therapeutics (DNLI) United States $3.487B 0.00
Reata Pharmaceuticals (RETA) United States $3.443B 0.00
Sorrento Therapeutics (SRNE) United States $3.410B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.317B 0.00
Fate Therapeutics (FATE) United States $3.013B 0.00
Insmed (INSM) United States $2.932B 0.00
Alkermes (ALKS) Ireland $2.895B 60.67
Principia Biopharma (PRNB) United States $2.795B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.640B 0.00
Amarin (AMRN) Ireland $2.540B 0.00
Inovio Pharmaceuticals (INO) United States $2.311B 0.00
Twist Bioscience (TWST) United States $2.278B 0.00
Editas Medicine (EDIT) United States $2.129B 0.00
Viela Bio (VIE) United States $1.855B 0.00
PHARMA MAR SA (PHMMF) Spain $1.833B 0.00
UniQure (QURE) Netherlands $1.808B 0.00
Ligand Pharmaceuticals (LGND) United States $1.799B 60.81
Intercept Pharmaceuticals (ICPT) United States $1.734B 0.00
Sangamo Therapeutics (SGMO) United States $1.712B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.682B 40.04
I-Mab (IMAB) China $1.668B 0.00
Eidos Therapeutics (EIDX) United States $1.629B 0.00
Revance Therapeutics (RVNC) United States $1.607B 0.00
Seres Therapeutics (MCRB) United States $1.528B 0.00
Cytokineticsorporated (CYTK) United States $1.486B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.471B 0.00
Zealand Pharma (ZEAL) Denmark $1.436B 0.00
Zymeworks (ZYME) Canada $1.379B 0.00
Coherus BioSciences (CHRS) United States $1.341B 7.82
Forma Therapeutics Holdings (FMTX) United States $1.340B 0.00
Mesoblast (MESO) Australia $1.323B 0.00
Epizyme (EPZM) United States $1.288B 0.00
NGM Biopharmaceuticals (NGM) United States $1.282B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Intra-Cellular Therapies (ITCI) United States $1.274B 0.00
Mersana Therapeutics (MRSN) United States $1.271B 0.00
Adverum Biotechnologies (ADVM) United States $1.257B 0.00
REGENXBIO (RGNX) United States $1.244B 0.00
Beam Therapeutics (BEAM) United States $1.216B 0.00
Alcobra (ARCT) United States $1.201B 0.00
Akcea Therapeutics (AKCA) United States $1.174B 0.00
Intellia Therapeutics (NTLA) United States $1.150B 0.00
Alector (ALEC) United States $1.134B 0.00
Compugen (CGEN) Israel $1.114B 0.00
Arvinas (ARVN) United States $1.096B 0.00
Arcus Biosciences (RCUS) United States $1.059B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.058B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.029B 0.00
NantKwest (NK) United States $1.020B 0.00
Heska (HSKA) United States $0.968B 0.00
Athenex (ATNX) United States $0.956B 0.00
Retrophin (RTRX) United States $0.930B 0.00
Myriad Genetics (MYGN) United States $0.927B 47.81
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.853B 0.00
Morphic Holding (MORF) United States $0.849B 0.00
VBI Vaccines (VBIV) United States $0.844B 0.00
Castle Biosciences (CSTL) United States $0.824B 0.00
Cara Therapeutics (CARA) United States $0.817B 0.00
Pharming Group (PHGUF) Netherlands $0.807B 18.43
Intrexon (PGEN) United States $0.793B 0.00
Codexis (CDXS) United States $0.776B 0.00
Dynavax Technologies (DVAX) United States $0.775B 0.00
Frequency Therapeutics (FREQ) United States $0.731B 0.00
Cellectis S.A (CLLS) France $0.731B 0.00
Vericel (VCEL) United States $0.729B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.726B 0.00
Kadmon Holdings (KDMN) United States $0.700B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.691B 0.00
MiMedx (MDXG) United States $0.660B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.654B 5.73
Sinovac Biotech (SVA) China $0.640B 20.87
Agenus (AGEN) United States $0.605B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Cue Biopharma (CUE) United States $0.593B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.568B 0.00
Syros Pharmaceuticals (SYRS) United States $0.550B 0.00
MeiraGTx Holdings (MGTX) United States $0.518B 0.00
UROGEN PHARMA (URGN) United States $0.506B 0.00
Kala Pharmaceuticals (KALA) United States $0.501B 0.00
Anika Therapeutics (ANIK) United States $0.498B 21.78
Prothena (PRTA) Ireland $0.498B 0.00
Innate Pharma S.A (IPHA) France $0.494B 0.00
AnaptysBio (ANAB) United States $0.476B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.468B 0.00
Protagonist Therapeutics (PTGX) United States $0.465B 0.00
BioDelivery Sciences (BDSI) United States $0.461B 32.64
Biofrontera AG (BFRA) Germany $0.456B 0.00
Cel-Sci (CVM) United States $0.452B 0.00
AC Immune SA (ACIU) Switzerland $0.449B 0.00
Athersys (ATHX) United States $0.446B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.445B 0.00
Pfenex (PFNX) United States $0.440B 0.00
Avid Bioservices (CDMO) United States $0.435B 0.00
Clovis Oncology (CLVS) United States $0.432B 0.00
Prometic Life Sciences (LMNL) Canada $0.421B 0.00
Albireo Pharma (ALBO) United States $0.402B 0.00
Puma Biotechnology (PBYI) United States $0.398B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.386B 0.00
ANI Pharmaceuticals (ANIP) United States $0.385B 9.07
Scholar Rock Holding (SRRK) United States $0.382B 0.00
Kamada (KMDA) Israel $0.379B 15.76
Merus (MRUS) Netherlands $0.377B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.368B 0.00
MannKind (MNKD) United States $0.367B 0.00
PDL BioPharma (PDLI) United States $0.362B 0.00
Trevena (TRVN) United States $0.361B 0.00
Precision BioSciences (DTIL) United States $0.350B 0.00
WAVE Life Sciences (WVE) Singapore $0.339B 0.00
IBio (IBIO) United States $0.327B 0.00
Geron (GERN) United States $0.325B 0.00
CytomX Therapeutics (CTMX) United States $0.323B 0.00
ChromaDex (CDXC) United States $0.294B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.290B 0.00
OSMOTICA PHARM (OSMT) United States $0.289B 0.00
Selecta Biosciences (SELB) United States $0.287B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.283B 0.00
Starpharma Holdings (SPHRY) Australia $0.283B 0.00
Arbutus Biopharma (ABUS) United States $0.278B 0.00
Cellular Biomedicine (CBMG) United States $0.277B 0.00
Spero Therapeutics (SPRO) United States $0.274B 0.00
Menlo Therapeutics (MNLO) United States $0.272B 0.00
Affimed (AFMD) Germany $0.265B 0.00
Fortress Biotech (FBIO) United States $0.264B 0.00
NextCure (NXTC) United States $0.259B 0.00
DBV Technologies S.A (DBVT) France $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.248B 0.00
Verastem (VSTM) United States $0.246B 0.00
Dyadic (DYAI) United States $0.245B 0.00
Abeona Therapeutics (ABEO) United States $0.244B 0.00
Northwest Biotherapeutics (NWBO) United States $0.243B 0.00
HOOKIPA Pharma (HOOK) United States $0.238B 0.00
Celldex Therapeutics (CLDX) United States $0.228B 0.00
IVERIC Bio (ISEE) United States $0.226B 0.00
Pluristem Therapeutics (PSTI) Israel $0.217B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.217B 0.00
Strongbridge Biopharma (SBBP) United States $0.216B 0.00
Cerecor (CERC) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 9.50
Theratechnologies (THTX) Canada $0.203B 0.00
Aduro Biotech (ADRO) United States $0.203B 0.00
Exicure (XCUR) United States $0.202B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.198B 0.00
Sutro Biopharma (STRO) United States $0.197B 0.00
GENFIT S.A (GNFT) France $0.194B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Aptinyx (APTX) United States $0.184B 0.00
XOMA (XOMA) United States $0.181B 0.00
Cyclerion Therapeutics (CYCN) United States $0.181B 0.00
Five Prime Therapeutics (FPRX) United States $0.174B 0.00
VTv Therapeutics (VTVT) United States $0.171B 0.00
Cidara Therapeutics (CDTX) United States $0.166B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.166B 0.00
Aytu Bioscience (AYTU) United States $0.158B 0.00
Bellus Health (BLU) Canada $0.157B 0.00
Kindred Biosciences (KIN) United States $0.156B 0.00
Liquidia Technologies (LQDA) United States $0.153B 0.00
TELA Bio (TELA) United States $0.151B 0.00
Applied Genetic Technologies (AGTC) United States $0.147B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Eton Pharmaceuticals (ETON) United States $0.144B 0.00
Celyad SA (CYAD) Belgium $0.141B 0.00
Gritstone Oncology (GRTS) United States $0.136B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.135B 0.00
VolitionRX (VNRX) United States $0.135B 0.00
Palatin Technologies (PTN) United States $0.130B 3.33
CorMedix Inc (CRMD) United States $0.128B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.126B 0.00
Orgenesis (ORGS) United States $0.124B 6.29
Lumos Pharma (LUMO) United States $0.123B 0.00
Oncobiologics (OTLK) United States $0.122B 0.00
Windtree Therapeutics (WINT) United States $0.122B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Cardiff Oncology (CRDF) United States $0.119B 0.00
Protalix BioTherapeutics (PLX) Israel $0.119B 0.00
SESEN BIO, INC (SESN) United States $0.118B 0.00
Checkpoint Therapeutics (CKPT) United States $0.116B 0.00
PHASEBIO PHARMA (PHAS) United States $0.113B 0.00
Cocrystal Pharma (COCP) United States $0.103B 0.00
Antibe Therapeutics (ATBPF) Canada $0.101B 0.00
Organovo Holdings (ONVO) United States $0.097B 0.00
AIT Therapeutics (XAIR) United States $0.094B 0.00
Vaccinex (VCNX) United States $0.093B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
AnPac Bio-Medical Science (ANPC) China $0.083B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.082B 0.00
Synlogic (SYBX) United States $0.082B 0.00
AquaBounty Technologies (AQB) United States $0.081B 0.00
Clearside Biomedical (CLSD) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Unum Therapeutics (UMRX) United States $0.078B 0.00
Ecology Coatings (ABVC) United States $0.077B 0.00
Idera Pharmaceuticals (IDRA) United States $0.076B 0.00
DiaMedica Therapeutics (DMAC) United States $0.076B 0.00
Emmaus Life Sciences (EMMA) United States $0.075B 0.00
Edesa Biotech (EDSA) Canada $0.072B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.070B 0.00
Proteostasis Therapeutics (PTI) United States $0.069B 0.00
Bionano Genomics (BNGO) United States $0.067B 0.00
Stealth BioTherapeutics (MITO) United States $0.066B 94.50
Signal Genetics (MGEN) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.065B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.063B 0.00
Soligenix (SNGX) United States $0.063B 0.00
Happiness Biotech Group (HAPP) China $0.058B 0.00
IMMURON (IMRN) Australia $0.057B 0.00
Genetic Technologies (GENE) Australia $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.054B 0.00
Prima BioMed (IMMP) Australia $0.053B 0.00
CollPlant Holdings (CLGN) Israel $0.052B 0.00
Apricus Biosciences (SEEL) United States $0.049B 0.00
Curis (CRIS) United States $0.047B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
Novogen (KZIA) Australia $0.041B 0.00
Prana Biotechnology (ATHE) Australia $0.039B 0.00
Celsion (CLSN) United States $0.038B 0.00
Spherix (AIKI) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.037B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.037B 0.00
Cesca Therapeutics (THMO) United States $0.036B 0.00
OvaScience (MLND) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
Cleveland BioLabs (CBLI) United States $0.031B 0.00
Forte Biosciences (FBRX) United States $0.031B 0.00
Evogene (EVGN) Israel $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.028B 0.00
Chanticleer Holdings (SONN) United States $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
MYOS RENS Technology (MYOS) United States $0.019B 0.00
BioCardia (BCDA) United States $0.018B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00